Genetic Diseases of Hypotension

Advances in Pharmacology

Volumn 42, Issue C, 1997, Pages 61-65

  Robertson, David ^a   Hale, Nannette ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956751805     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60696-1     Document Type: Article

References (23)

1. Robertson D., Goldberg M.R., Hollister A.S., Onrot J., Wiley R., Thompson J.G., and Robertson R.M. Isolated failure of autonomic noradrenergic neurotransmission: Evidence for impaired beta-hydroxylation of dopamine. N. Engl. J. Med. 314 (1986) 1494-1497
2. Man in't Veld A.J., Boomsma F., Moleman P., and Schalekamp M.A.D.H. Congenital dopamine-β-hydroxylase deficiency: A novel orthostatic syndrome. Lancet 1 (1987) 183-187
3. Biaggioni I., Goldstein D.D., Atkinson T., and Robertson D. Dopamine-beta-hydroxylase deficiency in humans. Neurology 40 (1990) 370-373
4. Man in't Veld A.J., Boomsma F., van den Meiracker A.H., and Schalekamp M.A.D.H. Effect of an unnatural noradrenaline precursor on sympathetic control and orthostatic hypotension in dopamine-P-hydroxylase deficiency. Lancet 2 (1987) 1172-1175
5. Mathias C.J., Bannister R.B., Cortelli P., Heslop K., Polak J.M., Raimbach S., Springall D.R., and Watson L. Clinical, autonomic and therapeutic observations in two siblings with postural hypotension and sympathetic failure due to inability to synthesize noradrenaline from dopamine because of a deficiency of dopamine beta hydroxylase. Q. J. Med. 75 (1990) 617-633
6. Thompson J.M., O'Callaghan C.J., Kingwell B.A., Lambert G.W., Jennings G.L., and Esler M.D. Total norepinephrine spillover, muscle sympathetic nerve activity and heart-rate spectral analysis in a patient with dopamine-hydroxylase deficiency. J. Auton. New. Syst. 55 (1995) 198-206
7. Robertson D., Hollister A.S., and Biaggioni I. Dopamine-beta-hydroxylase deficiency and cardiovascular control. In: Laragh J., and Brenner B.M. (Eds). "Hypertension: Pathophysiology, Management, and Diagnosis" (1990), Raven Press, New York 749-758
8. Robertson, D., Perry, S. E., Hollister, A. S., Robertson, R. M., and Biaggioni, I. Dopamine-β-hydroxylase deficiency: A genetic disorder of cardiovascular regulation. Hypertension 18, 1-8.
9. Craig S.P., Buckle V.J., Lamouroux A., Malet J., and Craig I.W. Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34 Cytogenet. Cell Genet. 48 (1988) 48-50
10. Kobayashi K., Morita S., Mizuguchi T., Sawada H., Yamada K., Nagatsu I., Fugita K., and Nagatsu T. Functional and high level expression of human dopamine-hydroxylase in transgenic mice. J. Biol. Chem. 47 (1994) 29725-29731
11. Robertson D., and Davis T. Recent advances in the treatment of orthostatic hypotension. Neurology 45 Suppl 4 (1995) S26-S32
12. Robertson, D. Autonomic failure In Handbook of Autonomic Nervous System Dysfunction. (A. D. Korczyn, ed.), pp. 129-148. Dekker, New York.
13. O'Connor D.T., Cervenka J.H., Stone R.A., Levine G.L., Palmer R.J., Franco-Bourland R.E., Madrazo I., Langlais P.J., Robertson D., and Biaggioni I. Dopamine 8-hydroxylase immtinoreactivity in human cerebrospinal fluid: Properties, relationship to central noradrenergic activity and variation in Parkinson's disease and congenital dopamine 8-hydroxylase deficiency. Clin. Sci. 86 (1994) 149-158
14. Kuchel O., Debinski W., Larochelle P., Robertson D., Hollister A.S., Biaggioni I., and Robertson R.M. Isolated failure of autonomic noradrenergic transmission. (Letter). N. Engl. J. Med. 315 (1986) 1357-1358
15. Man in't Veld A.J., Boomsma F., van den Meiracker A.H., and Schalekamp M.A.D.H. Effect of an unnatural noradrenaline precursor on sympathetic control and orthostatic hypotension in dopamine-β-hydroxylase deficiency. Lancet 2 (1987) 1172-1175
16. Biaggioni I., and Robertson D. Endogenous restoration of norepinephrine by precursor therapy in dopamine-beta-hydroxylase deficiency. Lancet 2 (1987) 1170-1172
17. Tulen J.H.M., Man in't Veld A.J., Dzoljic M.R., Melchese K., and Moleman P. D,L-threo-3,4-DOPS enhances rapid eye movement sleep in patients with congenital dopamine-hydroxylase deficiency. J. Clin. Psychopharmacol. 10 (1990) 73-74
18. Tulen J.H.M., Man in't Veld A.J., Dzoljic M.R., Melchese K., and Moleman P. Sleeping with and without norepinephrine: Effects of metoclopramide and D,L-3,4-dihydroxyphenylserine on sleep in dopamine beta-hydroxylase deficiency. Sleep 14 (1991) 32-38
19. Gray J. Criteria for selection and evaluation of good teaching cases. J. Clin Pharmacol. 32 (1992) 779-797
20. Hyland K. Tetrahydrobiopterin deficiency and aromatic L-amino acid decarboxylase deficiency. In: Robertson D., Low P.A., and Polinsky R.J. (Eds). "Primer on the Autonomic Nervous System" (1996), Academic Press, San Diego 201-204
21. Hoeldtke R. Menkes disease. In: Robertson D., Low P.A., and Polinsky R.J. (Eds). "Primer on the Autonomic Nervous System" (1996), Academic Press, San Diego 208-210
22. Breakefield X. Monoamine oxidase deficiency states. In: Robertson D., Low P.A., and Polinsky R.J. (Eds). "Primer on the Autonomic Nervous System" (1996), Academic Press, San Diego 210-212
23. Kuchel O. Disorders of catecholamine metabolism. In: Robertson D., Low P.A., and Polinsky R.J. (Eds). "Primer on the Autonomic Nervous System" (1996), Academic Press, San Diego 212-216